{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T22:40:13Z","timestamp":1731451213253,"version":"3.28.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,12]]},"DOI":"10.7759\/cureus.73553","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T22:03:05Z","timestamp":1731448985000},"source":"Crossref","is-referenced-by-count":0,"title":["Gastric Neuroendocrine Tumors and Pernicious Anemia: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"James J","family":"Rudolph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obed","family":"Agyei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talar","family":"Telvizian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Ghaneie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000140663","article-title":"From Leningrad to London: the saga of Kulchitsky and the legacy of the enterochromaffin cell","volume":"89","author":"Drozdov I","year":"2009","unstructured":"Drozdov I, Modlin IM, Kidd M, Goloubinov VV. From Leningrad to London: the saga of Kulchitsky and the legacy of the enterochromaffin cell. Neuroendocrinology. 2009, 89:1-12. 10.1159\/000140663","journal-title":"Neuroendocrinology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.09.018","article-title":"Siegfried Oberndorfer: origins and perspectives of carcinoid tumors","volume":"35","author":"Modlin IM","year":"2004","unstructured":"Modlin IM, Shapiro MD, Kidd M. Siegfried Oberndorfer: origins and perspectives of carcinoid tumors. Hum Pathol. 2004, 35:1440-51. 10.1016\/j.humpath.2004.09.018","journal-title":"Hum Pathol"},{"key":"ref3","article-title":"The eminent German pathologist Siegfried Oberndorfer (1876-1944) and his landmark work on carcinoid tumors","volume":"24","author":"Tsoucalas G","year":"2011","unstructured":"Tsoucalas G, Karamanou M, Androutsos G. The eminent German pathologist Siegfried Oberndorfer (1876-1944) and his landmark work on carcinoid tumors. Ann Gastroenterol. 2011, 24:98-100.","journal-title":"Ann Gastroenterol"},{"key":"ref4","article-title":"Endocrine tumors of the appendix [Article in French]","volume":"25","author":"Gosset A","year":"1914","unstructured":"Gosset A, Masson P. Endocrine tumors of the appendix [Article in French]. Presse Med. 1914, 25:237-40.","journal-title":"Presse Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0462-z","article-title":"Siegfried Oberndorfer: a tribute to his work and life between Munich, Kiel, Geneva, and Istanbul","volume":"451","author":"Kl\u00f6ppel G","year":"2007","unstructured":"Kl\u00f6ppel G, Dege K, Remmele W, Kapran Y, Tuzlali S, Modlin IM. Siegfried Oberndorfer: a tribute to his work and life between Munich, Kiel, Geneva, and Istanbul. Virchows Arch. 2007, 451:S3-7. 10.1007\/s00428-007-0462-z","journal-title":"Virchows Arch"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet J","year":"2015","unstructured":"Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015, 121:589-97. 10.1002\/cncr.29099","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/GICTT.S109028","article-title":"Gastric neuroendocrine tumors: management and challenges","volume":"7","author":"Kwon DH","year":"2017","unstructured":"Kwon DH, Nakakura EK, Bergsland EK, Dai SC. Gastric neuroendocrine tumors: management and challenges. Gastrointestinal Cancer: Targets and Therapy. 2017, 7:31-7. 10.2147\/GICTT.S109028","journal-title":"Gastrointestinal Cancer: Targets and Therapy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing but NET: a review of neuroendocrine tumors and carcinomas","volume":"19","author":"Oronsky B","year":"2017","unstructured":"Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017, 19:991-1002. 10.1016\/j.neo.2017.09.002","journal-title":"Neoplasia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v12.i8.791","article-title":"Gastrointestinal neuroendocrine tumors in 2020","volume":"12","author":"Ahmed M","year":"2020","unstructured":"Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol. 2020, 12:791-807. 10.4251\/wjgo.v12.i8.791","journal-title":"World J Gastrointest Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin IM","year":"2005","unstructured":"Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology. 2005, 128:1717-51. 10.1053\/j.gastro.2005.03.038","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000129342.67174.67","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard MA","year":"2004","unstructured":"Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004, 240:117-22. 10.1097\/01.sla.0000129342.67174.67","journal-title":"Ann Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari A","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al.. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017, 3:1335-42. 10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence B","year":"2011","unstructured":"Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011, 40:1-18, vii. 10.1016\/j.ecl.2010.12.005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-020-01046-8","article-title":"Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research","volume":"23","author":"Hu P","year":"2020","unstructured":"Hu P, Bai J, Liu M, et al.. Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research. Gastric Cancer. 2020, 23:591-9. 10.1007\/s10120-020-01046-8","journal-title":"Gastric Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s1095-6433(00)00331-7","article-title":"Control of gastric acid secretion: the gastrin-ECL cell-parietal cell axis","volume":"128","author":"Lindstr\u00f6m E","year":"2001","unstructured":"Lindstr\u00f6m E, Chen D, Norl\u00e9n P, Andersson K, H\u00e5kanson R. Control of gastric acid secretion: the gastrin-ECL cell-parietal cell axis. Comp Biochem Physiol A Mol Integr Physiol. 2001, 128:503-11. 10.1016\/s1095-6433(00)00331-7","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal ID","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al.. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020, 76:182-8. 10.1111\/his.13975","journal-title":"Histopathology"},{"key":"ref17","article-title":"Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants","volume":"122","author":"Matsui K","year":"1998","unstructured":"Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med. 1998, 122:1010-7.","journal-title":"Arch Pathol Lab Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v12.i8.850","article-title":"Gastric neuroendocrine tumor: A practical literature review","volume":"12","author":"Roberto GA","year":"2020","unstructured":"Roberto GA, Rodrigues CM, Peixoto RD, Younes RN. Gastric neuroendocrine tumor: A practical literature review. World J Gastrointest Oncol. 2020, 12:850-6. 10.4251\/wjgo.v12.i8.850","journal-title":"World J Gastrointest Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i30.6817","article-title":"Management of gastric and duodenal neuroendocrine tumors","volume":"22","author":"Sato Y","year":"2016","unstructured":"Sato Y, Hashimoto S, Mizuno K, Takeuchi M, Terai S. Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol. 2016, 22:6817-28. 10.3748\/wjg.v22.i30.6817","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1731427","article-title":"Gastric neuroendocrine tumor","volume":"7","author":"Kargwal N","year":"2021","unstructured":"Kargwal N, Panda V, Jha A, Singh CB. Gastric neuroendocrine tumor. Surg J (N Y). 2021, 7:e142-6. 10.1055\/s-0041-1731427","journal-title":"Surg J (N Y)"},{"key":"ref21","article-title":"Gastric carcinoid tumors","volume":"8","author":"Wardlaw R","year":"2008","unstructured":"Wardlaw R, Smith JW. Gastric carcinoid tumors. Ochsner J. 2008, 8:191-6.","journal-title":"Ochsner J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1023\/a:1017972204219","article-title":"Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection","volume":"47","author":"Sato Y","year":"2002","unstructured":"Sato Y, Iwafuchi M, Ueki J, et al.. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci. 2002, 47:579-85. 10.1023\/a:1017972204219","journal-title":"Dig Dis Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12691\/ajmcr-8-8-4","article-title":"Pernicious anemia and gastric carcinoid tumor: a case report and literature review","volume":"8","author":"Avila J","year":"2020","unstructured":"Avila J, Reyes I, Villacr\u00e9s L, et al.. Pernicious anemia and gastric carcinoid tumor: a case report and literature review. Am J Med Case Rep. 2020, 8:232-4. 10.12691\/ajmcr-8-8-4","journal-title":"Am J Med Case Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4253\/wjge.v7.i4.346","article-title":"Endoscopic diagnosis and management of type I neuroendocrine tumors","volume":"7","author":"Sato Y","year":"2015","unstructured":"Sato Y. Endoscopic diagnosis and management of type I neuroendocrine tumors. World J Gastrointest Endosc. 2015, 7:346-53. 10.4253\/wjge.v7.i4.346","journal-title":"World J Gastrointest Endosc"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3426-3_12","article-title":"Neuroendocrine neoplasms of the stomach","author":"Henderson-Jackson E","year":"2016","unstructured":"Henderson-Jackson E, Sheikh U, Muhammad J, Coppola D, Nasir A . Neuroendocrine neoplasms of the stomach. Neuroendocrine Tumors: Review of Pathology, Molecular and Therapeutic Advances. Springer, New York, NY; 2016. 217-244. 10.1007\/978-1-4939-3426-3_12"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2012.6.4.405","article-title":"Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors","volume":"6","author":"Kim MK","year":"2012","unstructured":"Kim MK. Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors. Gut Liver. 2012, 6:405-10. 10.5009\/gnl.2012.6.4.405","journal-title":"Gut Liver"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-019-0684-7","article-title":"Gastric neuroendocrine tumors (carcinoids)","volume":"21","author":"Gluckman CR","year":"2019","unstructured":"Gluckman CR, Metz DC. Gastric neuroendocrine tumors (carcinoids). Curr Gastroenterol Rep. 2019, 21:13. 10.1007\/s11894-019-0684-7","journal-title":"Curr Gastroenterol Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31828e34a4","article-title":"Consensus guidelines for the management and treatment of neuroendocrine tumors","volume":"42","author":"Kunz PL","year":"2013","unstructured":"Kunz PL, Reidy-Lagunes D, Anthony LB, et al.. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 2013, 42:557-77. 10.1097\/MPA.0b013e31828e34a4","journal-title":"Pancreas"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07143-7","article-title":"Metastasis prevalence and survival of patients with T1-2 gastric neuroendocrine tumor treated with endoscopic therapy and surgery","volume":"67","author":"Wang M","year":"2022","unstructured":"Wang M, Cheng S, Zhu L, et al.. Metastasis prevalence and survival of patients with T1-2 gastric neuroendocrine tumor treated with endoscopic therapy and surgery. Dig Dis Sci. 2022, 67:3228-38. 10.1007\/s10620-021-07143-7","journal-title":"Dig Dis Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14712-9","article-title":"Management of gastric neuroendocrine tumors: a review","volume":"31","author":"Sok C","year":"2024","unstructured":"Sok C, Ajay PS, Tsagkalidis V, Kooby DA, Shah MM. Management of gastric neuroendocrine tumors: a review. Ann Surg Oncol. 2024, 31:1509-18. 10.1245\/s10434-023-14712-9","journal-title":"Ann Surg Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01961-w","article-title":"Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes","volume":"46","author":"Massironi S","year":"2023","unstructured":"Massironi S, Rossi RE, Laffusa A, et al.. Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes. J Endocrinol Invest. 2023, 46:957-65. 10.1007\/s40618-022-01961-w","journal-title":"J Endocrinol Invest"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab903","article-title":"Secretin stimulation test and early diagnosis of gastrinoma in MEN1 syndrome: survey on the MEN1 florentine database","volume":"107","author":"Giusti F","year":"2022","unstructured":"Giusti F, Cioppi F, Fossi C, Marini F, Masi L, Tonelli F, Brandi ML.  Secretin stimulation test and early diagnosis of gastrinoma in MEN1 syndrome: survey on the MEN1 florentine database. J Clin Endocrinol Metab. 2022, 107:e2110-23. 10.1210\/clinem\/dgab903","journal-title":"J Clin Endocrinol Metab"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15082202","article-title":"Gastric neuroendocrine tumors (g-NETs): a systematic review of the management and outcomes of type 3 g-NETs","volume":"15","author":"Laffi A","year":"2023","unstructured":"Laffi A, Lania AG, Ragni A, et al.. Gastric neuroendocrine tumors (g-NETs): a systematic review of the management and outcomes of type 3 g-NETs. Cancers (Basel). 2023, 15:2202. 10.3390\/cancers15082202","journal-title":"Cancers (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v12.i12.1416","article-title":"Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours","volume":"12","author":"Li YL","year":"2020","unstructured":"Li YL, Qiu XD, Chen J, et al.. Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours. World J Gastrointest Oncol. 2020, 12:1416-27. 10.4251\/wjgo.v12.i12.1416","journal-title":"World J Gastrointest Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012101","article-title":"Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: a Digestive Endoscopy Society of Tawian (DEST)","volume":"97","author":"Chung CS","year":"2018","unstructured":"Chung CS, Tsai CL, Chu YY, et al.. Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: a Digestive Endoscopy Society of Tawian (DEST). Medicine (Baltimore). 2018, 97:e12101. 10.1097\/MD.0000000000012101","journal-title":"Medicine (Baltimore)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/den.13778","article-title":"Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study","volume":"33","author":"Hirasawa T","year":"2021","unstructured":"Hirasawa T, Yamamoto N, Sano T. Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study. Dig Endosc. 2021, 33:408-17. 10.1111\/den.13778","journal-title":"Dig Endosc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13306","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3","volume":"35","author":"Panzuto F","year":"2023","unstructured":"Panzuto F, Ramage J, Pritchard DM, et al.. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3. J Neuroendocrinol. 2023, 35:e13306. 10.1111\/jne.13306","journal-title":"J Neuroendocrinol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10901","article-title":"Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours","volume":"105","author":"Min BH","year":"2018","unstructured":"Min BH, Hong M, Lee JH, et al.. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. Br J Surg. 2018, 105:1480-6. 10.1002\/bjs.10901","journal-title":"Br J Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.179234","article-title":"Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions","volume":"57","author":"Deroose CM","year":"2016","unstructured":"Deroose CM, Hindi\u00e9 E, Kebebew E, Goichot B, Pacak K, Ta\u00efeb D, Imperiale A. Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions. J Nucl Med. 2016, 57:1949-56. 10.2967\/jnumed.116.179234","journal-title":"J Nucl Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2006.03.007","article-title":"Imaging of neuroendocrine tumors","volume":"36","author":"Rufini V","year":"2006","unstructured":"Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Semin Nucl Med. 2006, 36:228-47. 10.1053\/j.semnuclmed.2006.03.007","journal-title":"Semin Nucl Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S25620","article-title":"Optimal management of pernicious anemia","volume":"3","author":"Andres E","year":"2012","unstructured":"Andres E, Serraj K. Optimal management of pernicious anemia. J Blood Med. 2012, 3:97-103. 10.2147\/JBM.S25620","journal-title":"J Blood Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071310","article-title":"Autoimmune atrophic gastritis: A clinical review","volume":"16","author":"Castellana C","year":"2024","unstructured":"Castellana C, Eusebi LH, Dajti E, et al.. Autoimmune atrophic gastritis: A clinical review. Cancers (Basel). 2024, 16:1310. 10.3390\/cancers16071310","journal-title":"Cancers (Basel)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03390080071034","article-title":"Iron deficiency occurs frequently in patients with pernicious anemia","volume":"257","author":"Carmel R","year":"1987","unstructured":"Carmel R, Weiner JM, Johnson CS. Iron deficiency occurs frequently in patients with pernicious anemia. JAMA. 1987, 257:1081-3. 10.1001\/jama.1987.03390080071034","journal-title":"JAMA"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v89i8-S.7919","article-title":"Autoimmune diseases in autoimmune atrophic gastritis","volume":"89","author":"Rodriguez-Castro KI","year":"2018","unstructured":"Rodriguez-Castro KI, Franceschi M, Miraglia C, et al.. Autoimmune diseases in autoimmune atrophic gastritis. Acta Biomed. 2018, 89:100-3. 10.23750\/abm.v89i8-S.7919","journal-title":"Acta Biomed"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15317","article-title":"Determinants of diagnostic delay in autoimmune atrophic gastritis","volume":"50","author":"Lenti MV","year":"2019","unstructured":"Lenti MV, Miceli E, Cococcia S, et al.. Determinants of diagnostic delay in autoimmune atrophic gastritis. Aliment Pharmacol Ther. 2019, 50:167-75. 10.1111\/apt.15317","journal-title":"Aliment Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15394","article-title":"Editorial: determinants of diagnostic delay in autoimmune atrophic gastritis-a salutary lesson","volume":"50","author":"Walker MM","year":"2019","unstructured":"Walker MM. Editorial: determinants of diagnostic delay in autoimmune atrophic gastritis-a salutary lesson. Aliment Pharmacol Ther. 2019, 50:458-9. 10.1111\/apt.15394","journal-title":"Aliment Pharmacol Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-019-01074-7","article-title":"Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach","volume":"13","author":"Nehme F","year":"2020","unstructured":"Nehme F, Rowe K, Palko W, Tofteland N, Salyers W. Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach. Clin J Gastroenterol. 2020, 13:299-307. 10.1007\/s12328-019-01074-7","journal-title":"Clin J Gastroenterol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-7404(03)00034-3","article-title":"Carcinoid tumors of the stomach","volume":"12","author":"Modlin IM","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. Carcinoid tumors of the stomach. Surg Oncol. 2003, 12:153-72. 10.1016\/S0960-7404(03)00034-3","journal-title":"Surg Oncol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v15.i8.1451","article-title":"Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis","volume":"15","author":"Massironi S","year":"2023","unstructured":"Massironi S, Gallo C, Elvevi A, Stegagnini M, Coltro LA, Invernizzi P. Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis. World J Gastrointest Oncol. 2023, 15:1451-60. 10.4251\/wjgo.v15.i8.1451","journal-title":"World J Gastrointest Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.06.078","article-title":"AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review","volume":"161","author":"Shah SC","year":"2021","unstructured":"Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review. Gastroenterology. 2021, 161:1325-32.e7. 10.1053\/j.gastro.2021.06.078","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/278951-gastric-neuroendocrine-tumors-and-pernicious-anemia-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T22:03:08Z","timestamp":1731448988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/278951-gastric-neuroendocrine-tumors-and-pernicious-anemia-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.73553","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,12]]}}}